These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 401716)

  • 1. Evolution of bacterial sensitivity to fosfomycin in the Cindad Sanitaria 'Francisco Franco' in Barcelona.
    Crespo E; Roca de Viñals JA
    Chemotherapy; 1977; 23 Suppl 1():112-6. PubMed ID: 401716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility to fosfomycin of hospital strains isolated in Nantes (France). Frequency of mutation to resistance.
    Courtieu AL; Drugeon H; Billaudel S
    Chemotherapy; 1977; 23 Suppl 1():25-36. PubMed ID: 401717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolution of the sensitivity to fosfomycin over the past two years.
    Gobernado M; Santos M; Diosdado N; Pérez F
    Chemotherapy; 1977; 23 Suppl 1():99-103. PubMed ID: 832547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of sensitivity to fosfomycin at Jimenez Diaz Foundation.
    Alés JM
    Chemotherapy; 1977; 23 Suppl 1():94-8. PubMed ID: 401722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of fosfomycin.
    Rodriguez A; Olay T; Oliver LE; Vicente MV
    G Ital Chemioter; 1977; 23(2):95-103. PubMed ID: 414954
    [No Abstract]   [Full Text] [Related]  

  • 6. [The role of the culture medium in the sensitivity of Gram-negative stocks and their resistant mutants to fosfomycin. The influence of glucose-6-phosphate].
    Drugeon H; Courtieu AL
    Minerva Med; 1978 Dec; 69(59):4055-60. PubMed ID: 105326
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sensitivity to fosfomycin of bacteria isolated at the Pitié-Salpétrière Hospital in 1982 and 1983].
    Bismuth R; Jarlier V; Nicolas MH; Nguyen J; Truffot C
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):520-4. PubMed ID: 6431379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fosfomycin, antimicrobial activity in vitro and in vivo.
    Goto S
    Chemotherapy; 1977; 23 Suppl 1():63-74. PubMed ID: 401721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergism between fosfomycin and nalidixic acid in vitro.
    Ullmann U
    J Antimicrob Chemother; 1979 Sep; 5(5):612-3. PubMed ID: 115834
    [No Abstract]   [Full Text] [Related]  

  • 10. [Epidemiological aspects relating to the determination of fosfomycin sensitivity: results of a study on 300 strains isolated in a hospital milieu in Turin].
    Vanini GC; Moiraghi Ruggenini A; Grassi R; Maury F; Giardini F
    G Batteriol Virol Immunol; 1979; 71(1-6):73-84. PubMed ID: 488578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reevaluation of fosfomycin: clinical and laboratory studies.
    Dai ZY; Zhang YY; Zhang MF; Zhang ZL; Zhang JD; Liu YK
    Chin Med J (Engl); 1981 Oct; 94(10):645-52. PubMed ID: 6797798
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fosfomycin, a new antibiotic: in vitro activity compared with mezlocillin, cefuroxime and gentamicin].
    Lindenschmidt EG; Schassan HH
    Immun Infekt; 1980; 8(4):121-6. PubMed ID: 6453080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of multiresistant serotype 012 Pseudomonas aeruginosa to fosfomycin in combination with other antibiotics.
    Watine J; Bourrel C; Dubourdieu B; Gineston JL; Bories P; Durand M; Marre A; Formosa F; Brunel MP; Palliez J
    Pathol Biol (Paris); 1994 Apr; 42(4):293-5. PubMed ID: 7808781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Susceptibility testing with fosfomycin in an agar diffusion test on Mueller-Hinton agar].
    Grimm H; Haag R
    Immun Infekt; 1982 Jul; 10(4):159-63. PubMed ID: 6813250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro investigations on the action fosfomycin alone and in combination with other antibiotics on Pseudomonas aeruginosa and Serratia marcescens.
    Ullmann U; Lindemann B
    Arzneimittelforschung; 1980; 30(8):1247-9. PubMed ID: 6776966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The action of fosfomycin on the growth of Pseudomonas aeruginosa.
    Hardisson C; Llaneza J
    Chemotherapy; 1977; 23 Suppl 1():37-44. PubMed ID: 401719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibacterial activity of fosfomycin and of the association fosfomycin-rifampicin, upon gram negative bacteria (author's transl)].
    Zemelman R; González C; Mondaca MA
    Rev Med Chil; 1980 Dec; 108(12):1112-7. PubMed ID: 7302408
    [No Abstract]   [Full Text] [Related]  

  • 18. Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens.
    Karageorgopoulos DE; Wang R; Yu XH; Falagas ME
    J Antimicrob Chemother; 2012 Feb; 67(2):255-68. PubMed ID: 22096042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of sensitivity to fosfomycin in bacteria isolated in 1973, 1974 and 1975 in the Servicio de Microbiologia y Epidemiologia of the 'Clinica Puerta de Hierro', Madrid.
    Dámaso D; Moreno-López M; Martínez-Beltrán J
    Chemotherapy; 1977; Suppl 1():104-11. PubMed ID: 832509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Fosfomycin resistance of Pseudomonas aeruginosa clinical isolates recovered in Japan in 1996.
    Shimizu M; Shigeobu F; Miyakozawa I; Nakamura A; Suzuki M; Mizukoshi S; O'Hara K; Sawai T
    Antimicrob Agents Chemother; 2000 Jul; 44(7):2007-8. PubMed ID: 10970248
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.